Pause when the label and the promise part ways.

Assumption to set aside · Research wording is a quieter route to the same medicine.

Research wording cannot establish that a product is suitable for patient care

A “research use only” label describes a product meant for laboratory work rather than treating people. Ask why a product offered for your treatment has that label.

The Food and Drug Administration uses FDA as its short name. For weight drugs labelled for research and offered to people, its September 26, 2026 account warns of possible harm and unknown quality.

FDA’s letters warn that an injection can put germs or poisons past the body’s protective barriers.

A treatment promise on a sales page does not replace a conversation about the actual product.

Pause over a claim that a custom mix is approved

Compounding involves making or changing a medicine at a pharmacy or doctor’s practice, in place of the drug company’s finished product.

As of September 26, 2026, custom drug mixes are not FDA-approved. An advert that says otherwise gives a false picture.

A national drug code is an entry in a product directory; it does not mean FDA approved the medicine.

That code distinction reflects FDA’s position as of September 26, 2026, even when a listing appears on a government website.

Find the pharmacy behind the packaging

Semaglutide (Ozempic, Wegovy) is an ingredient in medicines for blood sugar control or weight loss. Tirzepatide (Mounjaro, Zepbound) also has products for those uses; each brand has its own approved uses. FDA found fake pharmacy names on some custom mixes of these ingredients. These uses and FDA’s findings were checked September 26, 2026.

Some named pharmacies did not exist; in other cases, a real pharmacy had not made the labelled product.

Get the name of the pharmacy supplying it and compare it with the Texas board record. Bring any mismatch to that pharmacy.

Get an explanation for unclear instructions

FDA received reports that some people needed hospital care after problems with custom semaglutide injections. Dose mistakes may have caused the harm; FDA’s account was checked September 26, 2026.

The reports included measuring errors by patients and calculation errors by health professionals.

Ask the prescriber and dispensing pharmacist to resolve instructions you cannot follow confidently. Keep the actual label available for that discussion.

Storage instructions differ by product; there is no rule that every peptide needs a refrigerator.

Can the pharmacy explain the label, storage and who to contact about a problem?

Know when reading needs to give way to help

MedlinePlus explains the emergency called anaphylaxis: a severe allergic reaction that threatens life. Breathing may become difficult, or the tongue or face may swell.

MedlinePlus urges emergency help for severe allergic symptoms: the nearest emergency room or a 911 call.

For reporting a medicine problem, FDA has a service called MedWatch that patients can use themselves.

A complaint goes to the board for that role

The Texas medical board takes complaints concerning doctors and physician assistants. For a nurse, the Texas nursing board handles the complaint.

The pharmacy board takes written complaints about licensed pharmacies and pharmacists, but it does not handle billing or price disputes.